Study: Gynecologic Cancer Survivors Fear Recurrence Regardless of Prognosis
A recent study from Cancer Nursing has shed more light on the profound impact gynecologic cancer has on survivors, even after treatment. In particular, the study highlighted the prevalence of fear of recurrence among gynecologic cancer survivors, regardless of their prognosis, and underscores the importance of support programs to address survivors’ needs adequately.
Through in-depth interviews with 20 women who had recently completed treatment for cervical, uterine, or ovarian cancer, the study revealed four prominent themes. First, the transition to life after treatment was described as brutal, leaving many feeling lonely and overwhelmed by the multifaceted challenges they faced. Second, fear of recurrence cast a shadow over their lives, becoming an overarching concern. Third, women expressed a need for continuous professional support and information-sharing, which they found lacking in the healthcare system. Finally, they felt that information about their condition and potential outcomes was not readily provided, leaving them feeling unprepared and exacerbating the difficulties of their experience.
OCRA recognizes the significance of empowering those facing gynecologic cancer with knowledge and support. Our programs help gynecologic cancer survivors and those in treatment to navigate their experience, from the moment of diagnosis, throughout treatment, and during the ups and downs of everyday life with cancer.
No one should face a gynecologic cancer alone. Visit Support & Education to learn more about OCRA’s Woman to Woman peer support program, Staying Connected virtual support series, Patient Information line, Inspire ovarian cancer forum, and more.
By addressing fear of recurrence and other challenges head-on, we strive to help patients and survivors feels less alone, and foster a community providing solace and strength in each other’s experiences. Together, we can create a brighter future for those who have faced gynecologic cancer.
Read more about the study in Oncology Nurse Advisor.